[Diseases of the peripheral nervous system].

VPS35 mutations in Parkinson disease. Am J Hum Genet (2011) 4.16

Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal Chem (2008) 3.04

Out-of-body experience and autoscopy of neurological origin. Brain (2003) 2.66

Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoring. IEEE Trans Biomed Eng (2004) 2.32

The metaphysical art of Giorgio de Chirico. Migraine or epilepsy? Eur Neurol (2003) 2.29

Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord (2004) 2.19

Phantosmias and Parkinson disease. Arch Neurol (2008) 2.13

Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke (2004) 2.11

Transforaminal Doppler: an alternative to transtemporal approach for right-to-left cardiac shunt assessment. J Neurol Sci (2008) 2.02

Stimulating illusory own-body perceptions. Nature (2002) 2.01

PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem (2005) 1.94

Linking out-of-body experience and self processing to mental own-body imagery at the temporoparietal junction. J Neurosci (2005) 1.71

Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring system. IEEE Trans Biomed Eng (2007) 1.68

Ambulatory monitoring of physical activities in patients with Parkinson's disease. IEEE Trans Biomed Eng (2007) 1.66

Vertebral artery hypoplasia: a predisposing factor for posterior circulation stroke? Neurology (2007) 1.65

Persisting vasculitis after pneumococcal meningitis. Neurocrit Care (2006) 1.58

Levodopa in the treatment of Parkinson's disease: an old drug still going strong. Clin Interv Aging (2010) 1.49

Skull base cerebrospinal fluid fistula: a novel detection method based on two-dimensional electrophoresis. Head Neck (2004) 1.39

128-channel EEG source imaging in epilepsy: clinical yield and localization precision. J Clin Neurophysiol (2004) 1.37

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain (2008) 1.24

Acute infarction limited to the lenticular nucleus: clinical, etiologic, and topographic features. Arch Neurol (2003) 1.18

Right parietal brain activity precedes perceptual alternation of bistable stimuli. Cereb Cortex (2008) 1.17

Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol Cell Proteomics (2003) 1.12

ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics (2004) 1.11

Prediction of response speed by anticipatory high-frequency (gamma band) oscillations in the human brain. Hum Brain Mapp (2005) 1.11

Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics (2004) 1.09

Giant plexiform neurofibroma in neurofibromatosis type 1. Arch Neurol (2010) 1.09

Electrical neuroimaging reveals early generator modulation to emotional words. Neuroimage (2004) 1.07

Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration. Proteomics (2004) 1.07

Velocity control in Parkinson's disease: a quantitative analysis of isochrony in scribbling movements. Exp Brain Res (2009) 1.06

Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke. J Thromb Thrombolysis (2007) 1.03

Very high frequency oscillations (VHFO) as a predictor of movement intentions. Neuroimage (2006) 1.02

Neural mechanisms of embodiment: asomatognosia due to premotor cortex damage. Arch Neurol (2006) 1.02

Electrophysiological evidence for early non-conscious processing of fearful facial expressions. Int J Psychophysiol (2008) 1.00

Restless arms. Lancet (2008) 0.99

Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process? Proteomics (2005) 0.99

The neural substrates and timing of top-down processes during coarse-to-fine categorization of visual scenes: a combined fMRI and ERP study. J Cogn Neurosci (2010) 0.98

Motor control and cerebral hemispheric specialization in highly qualified judo wrestlers. Neuropsychologia (2002) 0.96

State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research. Nat Protoc (2006) 0.96

Visual recognition of faces, objects, and words using degraded stimuli: where and when it occurs. Hum Brain Mapp (2004) 0.95

Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid. J Proteome Res (2006) 0.94

Brain extracellular fluid protein changes in acute stroke patients. J Proteome Res (2011) 0.93

Hyperfamiliarity for unknown faces after left lateral temporo-occipital venous infarction: a double dissociation with prosopagnosia. Brain (2003) 0.92

Hemispheric specialization of human inferior temporal cortex during coarse-to-fine and fine-to-coarse analysis of natural visual scenes. Neuroimage (2005) 0.91

Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Mov Disord (2007) 0.91

Bilateral compressive lumbosacral plexopathy due to internal iliac artery aneurysms. J Neurol (2006) 0.91

Electrophysiological correlates of affective blindsight. Neuroimage (2008) 0.91

Nonaccidental arterial cerebral air embolism: a ten-year stroke center experience. Cerebrovasc Dis (2013) 0.90

Isolated unilateral adduction deficit and ptosis as the presenting features of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroophthalmol (2002) 0.90

Seeing the phantom: a functional magnetic resonance imaging study of a supernumerary phantom limb. Ann Neurol (2009) 0.89

Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomark Insights (2007) 0.89

A novel approach to reducing number of sensing units for wearable gait analysis systems. IEEE Trans Biomed Eng (2012) 0.89

Etiologies of Parkinsonism in a century-long autopsy-based cohort. Brain Pathol (2012) 0.89

Levetiracetam accumulation in renal failure causing myoclonic encephalopathy with triphasic waves. Seizure (2009) 0.89

Proteomics in human Parkinson's disease research. J Proteomics (2009) 0.88

Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy. Metab Brain Dis (2002) 0.88

Neuropathology of dementia in a large cohort of patients with Parkinson's disease. Parkinsonism Relat Disord (2013) 0.87

On the origin of the N400 effects: an ERP waveform and source localization analysis in three matching tasks. Brain Topogr (2010) 0.87

Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy. Arch Neurol (2006) 0.87

Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. J Proteomics (2012) 0.86

Neural processing of illusory and real contours revealed by high-density ERP mapping. Neuroreport (2002) 0.86

Spatiotemporal Dynamics of Human Cognition. News Physiol Sci (1999) 0.86

Brain state-dependent functional hemispheric specialization in men but not in women. Cereb Cortex (2005) 0.86

Polyopic heautoscopy: Case report and review of the literature. Cortex (2006) 0.86

A glimpse into your vision. Hum Brain Mapp (2007) 0.85

A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics (2003) 0.85

Fulminant Lewy body disease. Mov Disord (2006) 0.84

Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis. Proteomics Clin Appl (2014) 0.84

Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy Bodies. Clin Nucl Med (2016) 0.84

Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns? Brain Cogn (2008) 0.83

Localization of electrodes in the subthalamic nucleus on magnetic resonance imaging. J Neurosurg (2007) 0.83

Pluripotent stem cells as new drugs? The example of Parkinson's disease. Int J Pharm (2009) 0.83

Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease? Mov Disord (2006) 0.83

Colour neglect in an artist. Lancet (2003) 0.83

Brain damage and addictive behavior: a neuropsychological and electroencephalogram investigation with pathologic gamblers. Cogn Behav Neurol (2003) 0.83

Compulsive singing: another aspect of punding in Parkinson's disease. Ann Neurol (2007) 0.83

Prostaglandin D2 synthase and its post-translational modifications in neurological disorders. Electrophoresis (2005) 0.83

Age-related proteome analysis of the mouse brain: a 2-DE study. Proteomics (2006) 0.83

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Arch Neurol (2006) 0.83

Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis. Proteomics (2014) 0.82

Psychometric schizotypy modulates levodopa effects on lateralized lexical decision performance. J Psychiatr Res (2005) 0.82

Postictal but not interictal hemispatial neglect in patients with seizures of lateralized onset. Epilepsia (2006) 0.82

TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse. Behav Neurosci (2002) 0.81

Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes. Transpl Int (2002) 0.81

Why revelations have occurred on mountains? Linking mystical experiences and cognitive neuroscience. Med Hypotheses (2005) 0.81

Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study. Arch Neurol (2004) 0.81

Subthalamic nucleus deep brain stimulation for Parkinson's disease: magnetic resonance imaging targeting using visible anatomical landmarks. Stereotact Funct Neurosurg (2003) 0.81

Blood glutathione S-transferase-π as a time indicator of stroke onset. PLoS One (2012) 0.81

Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs. Neuropsychiatr Dis Treat (2006) 0.81

Rhyme processing in the brain: an ERP mapping study. Int J Psychophysiol (2007) 0.80

Dynamics of brain activation during an explicit word and image recognition task: an electrophysiological study. Brain Topogr (2002) 0.80

Room tilt illusion influenced by head position. J Neuroophthalmol (2007) 0.80

Dyskinesia-induced postural instability in Parkinson's disease. Parkinsonism Relat Disord (2008) 0.80